Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Webb

Showing results (21-30 of 323) with videos related to

Pageof 33
Sort By:
British Journal of Clinical Pharmacology|July 5, 2025
Health technology assessment (HTA): Decisions on treatment efficiency guided by clinical judgement and pharmacoeconomicsKenneth R Paterson, David J Webb
Arteriosclerosis, Thrombosis, and Vascular Biology|March 5, 2003
Noninvasive assessment of arterial stiffness and risk of atherosclerotic eventsJames J Oliver, David J Webb
Hypertension (Dallas, Tex. : 1979)|August 16, 2006
Arterial blood pressure and stiffness in hypertension: is arterial structure important?Rupert A Payne, David J Webb
Circulation|November 20, 2013
Letter by Payne and Webb regarding article, "agreement among cardiovascular disease risk calculators"Rupert A Payne, David J Webb
Methods in Molecular Biology (Clifton, N.J.)|August 3, 2002
Local forearm vasoconstriction to endothelin-1 measured by venous occlusion plethysmography in vivoFiona E Strachan, David J Webb
British Journal of Clinical Pharmacology|January 12, 2007
Disease mongering -- a challenge for everyone involved in healthcareJames W Dear, David J Webb
Experimental Biology and Medicine (Maywood, N.J.)|June 3, 2006
Clinical trials of endothelin antagonists in heart failure: a question of dose?Nicholas F Kelland, David J Webb
Hypertension (Dallas, Tex. : 1979)|November 21, 2007
Peripheral augmentation index: shouldering the central pressure loadRupert A Payne, David J Webb
Expert Opinion on Investigational Drugs|May 9, 2002
Nitric oxide donor drugs: current status and future trendsIan L Megson, David J Webb
Lancet (London, England)|February 12, 2005
COX-2 selective inhibitors--important lessons learnedSimon R J Maxwell, David J Webb
Pageof 33

Showing results (21-30 of 323) with videos related to

Sort By:
Pageof 33
British Journal of Clinical Pharmacology|July 5, 2025
Health technology assessment (HTA): Decisions on treatment efficiency guided by clinical judgement and pharmacoeconomicsKenneth R Paterson, David J Webb
Arteriosclerosis, Thrombosis, and Vascular Biology|March 5, 2003
Noninvasive assessment of arterial stiffness and risk of atherosclerotic eventsJames J Oliver, David J Webb
Hypertension (Dallas, Tex. : 1979)|August 16, 2006
Arterial blood pressure and stiffness in hypertension: is arterial structure important?Rupert A Payne, David J Webb
Circulation|November 20, 2013
Letter by Payne and Webb regarding article, "agreement among cardiovascular disease risk calculators"Rupert A Payne, David J Webb
Methods in Molecular Biology (Clifton, N.J.)|August 3, 2002
Local forearm vasoconstriction to endothelin-1 measured by venous occlusion plethysmography in vivoFiona E Strachan, David J Webb
British Journal of Clinical Pharmacology|January 12, 2007
Disease mongering -- a challenge for everyone involved in healthcareJames W Dear, David J Webb
Experimental Biology and Medicine (Maywood, N.J.)|June 3, 2006
Clinical trials of endothelin antagonists in heart failure: a question of dose?Nicholas F Kelland, David J Webb
Hypertension (Dallas, Tex. : 1979)|November 21, 2007
Peripheral augmentation index: shouldering the central pressure loadRupert A Payne, David J Webb
Expert Opinion on Investigational Drugs|May 9, 2002
Nitric oxide donor drugs: current status and future trendsIan L Megson, David J Webb
Lancet (London, England)|February 12, 2005
COX-2 selective inhibitors--important lessons learnedSimon R J Maxwell, David J Webb
Pageof 33